Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Broad coverage of neutralization-resistant SIV strains by second-generation SIV-specific antibodies targeting the region involved in binding CD4

PLoS Pathogens(2022)10.1371/journal.ppat.1010574Source: DataRank Database

Broad coverage of neutralization-resistant SIV strains by second-generation SIV-specific antibodies targeting the region involved in binding CD4 is a research paper published in PLoS Pathogens (2022). On theSindex it has a DataRank of 0. It has been cited 17 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access17 citations

Download PDF

Cite:

Linked data & code

gen pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)OA: goldTopics (24)IDs (PubMed, PMC)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (23)

Hannah A. D. King ORCID,Leonard Nettey ORCID,Nicole Cavett,Jason Gorman ORCID,Tongqing Zhou ORCID

Live enrichment

PubMed:35709309 PMC:PMC9242510

Intramural Research Programs of the Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health

Grant: NIH HHSN272201800004C

Frederick National Laboratory for Cancer Research, National Institutes of Health

Grant: NIH HHSN261200800001

Frederick National Laboratory for Cancer Research, National Institutes of Health

Grant: RO1-AI112456

NIAID NIH HHS

Grant: HHSN272201800004C

CCR NIH HHS

Grant: HHSN261200800001C

NIAID NIH HHS

Grant: R01 AI112456

NCI NIH HHS

Grant: HHSN261200800001E

National Institutes of Health

Grant: 5R01AI112456-04

Non-CD4 tropic SIV: Enhancing CD4 T-cell help in antiviral immune responses

goldLicense: cc-by

publisherhttps://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1010574&type=printable

publisherhttps://dx.plos.org/10.1371/journal.ppat.1010574

repositoryhttps://doaj.org/article/4be5c204019f42f9a419f3dd8f3193f7

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9242510

Europe_PMChttps://europepmc.org/articles/PMC9242510

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

AnimalsMacaca mulattaHIV-1HIV InfectionsHIV AntibodiesSimian immunodeficiency virusAntibodies, NeutralizingBroadly Neutralizing Antibodies

Keywords

QH301-705.5HIV InfectionsRC581-607HIV AntibodiesAntibodies, NeutralizingMacaca mulattaHIV-1AnimalsSimian Immunodeficiency VirusImmunologic diseases. AllergyBiology (General)Broadly Neutralizing AntibodiesResearch Article

Sustainable Development Goals

SDG 3: 3. Good health

Broad coverage of neutralization-resistant SIV strains by second-generation SIV-specific antibodies targeting the region involved in binding CD4

FAIR Checklist

Authors (23)

Funding (8 grants)

Open Access

Topics

Annotations (Europe PMC)